Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618745.RArRm3f_yEyBCjtt9mOBzz_NgjpBA04cctqYXlIfq6zxU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618745.RArRm3f_yEyBCjtt9mOBzz_NgjpBA04cctqYXlIfq6zxU130_assertion type Assertion NP618745.RArRm3f_yEyBCjtt9mOBzz_NgjpBA04cctqYXlIfq6zxU130_head.
- NP618745.RArRm3f_yEyBCjtt9mOBzz_NgjpBA04cctqYXlIfq6zxU130_assertion description "[EGFR kinase inhibitors constitute an important class of lung cancer treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618745.RArRm3f_yEyBCjtt9mOBzz_NgjpBA04cctqYXlIfq6zxU130_provenance.
- NP618745.RArRm3f_yEyBCjtt9mOBzz_NgjpBA04cctqYXlIfq6zxU130_assertion evidence source_evidence_literature NP618745.RArRm3f_yEyBCjtt9mOBzz_NgjpBA04cctqYXlIfq6zxU130_provenance.
- NP618745.RArRm3f_yEyBCjtt9mOBzz_NgjpBA04cctqYXlIfq6zxU130_assertion SIO_000772 17613432 NP618745.RArRm3f_yEyBCjtt9mOBzz_NgjpBA04cctqYXlIfq6zxU130_provenance.
- NP618745.RArRm3f_yEyBCjtt9mOBzz_NgjpBA04cctqYXlIfq6zxU130_assertion wasDerivedFrom befree-2016 NP618745.RArRm3f_yEyBCjtt9mOBzz_NgjpBA04cctqYXlIfq6zxU130_provenance.
- NP618745.RArRm3f_yEyBCjtt9mOBzz_NgjpBA04cctqYXlIfq6zxU130_assertion wasGeneratedBy ECO_0000203 NP618745.RArRm3f_yEyBCjtt9mOBzz_NgjpBA04cctqYXlIfq6zxU130_provenance.